BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32285433)

  • 1. Smoking as a risk factor of onset and relapse of Multiple Sclerosis - a review.
    Jasielski P; Piędel F; Rocka A; Petit V; Rejdak K
    Neurol Neurochir Pol; 2020; 54(3):243-251. PubMed ID: 32285433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
    McKay KA; Jahanfar S; Duggan T; Tkachuk S; Tremlett H
    Neurotoxicology; 2017 Jul; 61():189-212. PubMed ID: 27045883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
    Jernas Ł; Piorunek T; Tokarz E; Wygladalska-Jernas H; Kozubski W; Michalak S
    Przegl Lek; 2012; 69(10):750-2. PubMed ID: 23421025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Health Policies on E-Cigarettes.
    Bhalerao A; Sivandzade F; Archie SR; Cucullo L
    Curr Cardiol Rep; 2019 Aug; 21(10):111. PubMed ID: 31463564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis.
    Weiland TJ; Hadgkiss EJ; Jelinek GA; Pereira NG; Marck CH; van der Meer DM
    J Neurol Sci; 2014 Jan; 336(1-2):211-9. PubMed ID: 24290614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What role does tobacco smoking play in multiple sclerosis disability and mortality? A review of the evidence.
    Weston M; Constantinescu CS
    Neurodegener Dis Manag; 2015; 5(1):19-25. PubMed ID: 25711451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Nicotine Dependence in E-Cigarettes' Potential for Smoking Reduction.
    Selya AS; Dierker L; Rose JS; Hedeker D; Mermelstein RJ
    Nicotine Tob Res; 2018 Sep; 20(10):1272-1277. PubMed ID: 29065204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifiable risk factors for poor health outcomes in multiple sclerosis: The urgent need for research to maximise smoking cessation success.
    Marck CH; das Nair R; Grech LB; Borland R; Constantinescu CS
    Mult Scler; 2020 Mar; 26(3):266-271. PubMed ID: 31219393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Sclerosis and Smoking.
    Arneth B
    Am J Med; 2020 Jul; 133(7):783-788. PubMed ID: 32259516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Burton JM; O'Connor PW; Hohol M; Beyene J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006921. PubMed ID: 23235634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic cigarettes and mental illness: Reviewing the evidence for help and harm among those with psychiatric and substance use disorders.
    Hefner K; Valentine G; Sofuoglu M
    Am J Addict; 2017 Jun; 26(4):306-315. PubMed ID: 28152247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings.
    Jakimovski D; Guan Y; Ramanathan M; Weinstock-Guttman B; Zivadinov R
    Neurodegener Dis Manag; 2019 Jun; 9(3):149-172. PubMed ID: 31116081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaping
    Rehan HS; Maini J; Hungin APS
    Curr Drug Saf; 2018; 13(2):92-101. PubMed ID: 29485005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic cigarettes and indoor air quality: a review of studies using human volunteers.
    Zainol Abidin N; Zainal Abidin E; Zulkifli A; Karuppiah K; Syed Ismail SN; Amer Nordin AS
    Rev Environ Health; 2017 Sep; 32(3):235-244. PubMed ID: 28107173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity.
    Valentine GW; Hefner K; Jatlow PI; Rosenheck RA; Gueorguieva R; Sofuoglu M
    J Dual Diagn; 2018; 14(1):2-13. PubMed ID: 29083287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
    Asadollahi S; Fakhri M; Heidari K; Zandieh A; Vafaee R; Mansouri B
    J Clin Neurosci; 2013 Dec; 20(12):1747-50. PubMed ID: 23972559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette Smoking, Alcohol Consumption and Overweight in Multiple Sclerosis: Disability Progression.
    Paz-Ballesteros WC; Monterrubio-Flores EA; de Jesús Flores-Rivera J; Corona-Vázquez T; Hernández-Girón C
    Arch Med Res; 2017 Jan; 48(1):113-120. PubMed ID: 28577864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of smoking on multiple sclerosis: a meta-analysis.
    Poorolajal J; Bahrami M; Karami M; Hooshmand E
    J Public Health (Oxf); 2017 Jun; 39(2):312-320. PubMed ID: 27160862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking and worsening disability in multiple sclerosis: A meta-analysis.
    Heydarpour P; Manouchehrinia A; Beiki O; Mousavi SE; Abdolalizadeh A; -Lakeh MM; Sahraian MA
    Acta Neurol Scand; 2018 Jul; 138(1):62-69. PubMed ID: 29542102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.